Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Lung Cancer

Free Subscription Articles published in Proc Natl Acad Sci U S A Retrieve available abstracts of 28 articles: HTML format Text format

Single Articles

October 2018
1. SHI L, Li K, Guo Y, Banerjee A, et al
   Modulation of NKG2D, NKp46, and Ly49C/I facilitates natural killer cell-mediated control of lung cancer.
   Proc Natl Acad Sci U S A. 2018 Oct 31. pii: 1804931115.
   PubMed     Text format     Abstract available
   
   
   
2. XIAO GY, Mohanakrishnan A, Schmid SL
   Role for ERK1/2-dependent activation of FCHSD2 in cancer cell-selective regulation of clathrin-mediated endocytosis.
   Proc Natl Acad Sci U S A. 2018;115:E9570-E9579.
   PubMed     Text format     Abstract available
   
   
   
3. GENNARO VJ, Stanek TJ, Peck AR, Sun Y, et al
   Control of CCND1 ubiquitylation by the catalytic SAGA subunit USP22 is essential for cell cycle progression through G1 in cancer cells.
   Proc Natl Acad Sci U S A. 2018;115:E9298-E9307.
   PubMed     Text format     Abstract available
   
   
   September 2018
4. MORGAN MJ, Fitzwalter BE, Owens CR, Powers RK, et al
   Metastatic cells are preferentially vulnerable to lysosomal inhibition.
   Proc Natl Acad Sci U S A. 2018;115:E8479-E8488.
   PubMed     Text format     Abstract available
   
   
   August 2018
5. LI L, Li JC, Yang H, Zhang X, et al
   Expansion of cancer stem cell pool initiates lung cancer recurrence before angiogenesis.
   Proc Natl Acad Sci U S A. 2018 Aug 29. pii: 1806219115.
   PubMed     Text format     Abstract available
   
   
   July 2018
6. HOSOYA T, Sato-Kaneko F, Ahmadi A, Yao S, et al
   Induction of oligoclonal CD8 T cell responses against pulmonary metastatic cancer by a phospholipid-conjugated TLR7 agonist.
   Proc Natl Acad Sci U S A. 2018;115:E6836-E6844.
   PubMed     Text format     Abstract available
   
   
   
7. WENG MW, Lee HW, Park SH, Hu Y, et al
   Aldehydes are the predominant forces inducing DNA damage and inhibiting DNA repair in tobacco smoke carcinogenesis.
   Proc Natl Acad Sci U S A. 2018;115:E6152-E6161.
   PubMed     Text format     Abstract available
   
   
   June 2018
8. FAN PD, Narzisi G, Jayaprakash AD, Venturini E, et al
   YES1 amplification is a mechanism of acquired resistance to EGFR inhibitors identified by transposon mutagenesis and clinical genomics.
   Proc Natl Acad Sci U S A. 2018;115:E6030-E6038.
   PubMed     Text format     Abstract available
   
   
   
9. DE SEMIR D, Bezrookove V, Nosrati M, Dar AA, et al
   PHIP as a therapeutic target for driver-negative subtypes of melanoma, breast, and lung cancer.
   Proc Natl Acad Sci U S A. 2018 Jun 4. pii: 1804779115.
   PubMed     Text format     Abstract available
   
   
   May 2018
10. LEITHNER K, Triebl A, Trotzmuller M, Hinteregger B, et al
    The glycerol backbone of phospholipids derives from noncarbohydrate precursors in starved lung cancer cells.
    Proc Natl Acad Sci U S A. 2018 May 29. pii: 1719871115.
    PubMed     Text format     Abstract available
    
    
    
11. WU L, Zhang H, Jiang Y, Gallo RC, et al
    Induction of antitumor cytotoxic lymphocytes using engineered human primary blood dendritic cells.
    Proc Natl Acad Sci U S A. 2018;115:E4453-E4462.
    PubMed     Text format     Abstract available
    
    
    April 2018
12. WU Q, Tian Y, Zhang J, Tong X, et al
    In vivo CRISPR screening unveils histone demethylase UTX as an important epigenetic regulator in lung tumorigenesis.
    Proc Natl Acad Sci U S A. 2018;115:E3978-E3986.
    PubMed     Text format     Abstract available
    
    
    
13. XU H, Lee MS, Tsai PY, Adler AS, et al
    Ablation of insulin receptor substrates 1 and 2 suppresses Kras-driven lung tumorigenesis.
    Proc Natl Acad Sci U S A. 2018;115:4228-4233.
    PubMed     Text format     Abstract available
    
    
    
14. ZHAO L, Huang S, Mei S, Yang Z, et al
    Pharmacological activation of estrogen receptor beta augments innate immunity to suppress cancer metastasis.
    Proc Natl Acad Sci U S A. 2018;115:E3673-E3681.
    PubMed     Text format     Abstract available
    
    
    March 2018
15. ROBICHAUD N, Hsu BE, Istomine R, Alvarez F, et al
    Translational control in the tumor microenvironment promotes lung metastasis: Phosphorylation of eIF4E in neutrophils.
    Proc Natl Acad Sci U S A. 2018;115:E2202-E2209.
    PubMed     Text format     Abstract available
    
    
    February 2018
16. 
    Correction for Goncalves et al., Fenofibrate prevents skeletal muscle loss in mice with lung cancer.
    Proc Natl Acad Sci U S A. 2018 Feb 20. pii: 1801372115.
    PubMed     Text format    
    
    
    January 2018
17. SONG NY, Zhu F, Wang Z, Willette-Brown J, et al
    IKKalpha inactivation promotes Kras-initiated lung adenocarcinoma development through disrupting major redox regulatory pathways.
    Proc Natl Acad Sci U S A. 2018;115:E812-E821.
    PubMed     Text format     Abstract available
    
    
    
18. KHANDEKAR MJ, Banks AS, Laznik-Bogoslavski D, White JP, et al
    Noncanonical agonist PPARgamma ligands modulate the response to DNA damage and sensitize cancer cells to cytotoxic chemotherapy.
    Proc Natl Acad Sci U S A. 2018;115:561-566.
    PubMed     Text format     Abstract available
    
    
    
19. GONCALVES MD, Hwang SK, Pauli C, Murphy CJ, et al
    Fenofibrate prevents skeletal muscle loss in mice with lung cancer.
    Proc Natl Acad Sci U S A. 2018 Jan 8. pii: 1714703115.
    PubMed     Text format     Abstract available
    
    
    November 2017
20. YAO K, Peng C, Zhang Y, Zykova TA, et al
    RSK2 phosphorylates T-bet to attenuate colon cancer metastasis and growth.
    Proc Natl Acad Sci U S A. 2017 Nov 13. pii: 201710756.
    PubMed     Text format     Abstract available
    
    
    August 2017
21. CHANG YS, Jalgaonkar SP, Middleton JD, Hai T, et al
    Stress-inducible gene Atf3 in the noncancer host cells contributes to chemotherapy-exacerbated breast cancer metastasis.
    Proc Natl Acad Sci U S A. 2017 Aug 7. pii: 201700455.
    PubMed     Text format     Abstract available
    
    
    June 2017
22. GOCHEVA V, Naba A, Bhutkar A, Guardia T, et al
    Quantitative proteomics identify Tenascin-C as a promoter of lung cancer progression and contributor to a signature prognostic of patient survival.
    Proc Natl Acad Sci U S A. 2017 Jun 26. pii: 201707054.
    PubMed     Text format     Abstract available
    
    
    April 2017
23. KAMPHORST AO, Pillai RN, Yang S, Nasti TH, et al
    Proliferation of PD-1+ CD8 T cells in peripheral blood after PD-1-targeted therapy in lung cancer patients.
    Proc Natl Acad Sci U S A. 2017 Apr 26. pii: 201705327.
    PubMed     Text format     Abstract available
    
    
    
24. 
    Editorial Expression of Concern: WWOX gene restoration prevents lung cancer growth in vitro and in vivo.
    Proc Natl Acad Sci U S A. 2017 Apr 3. pii: 201704296.
    PubMed     Text format    
    
    
    March 2017
25. 
    Correction for Tang et al., High-throughput screening of rare metabolically active tumor cells in pleural effusion and peripheral blood of lung cancer patients.
    Proc Natl Acad Sci U S A. 2017 Mar 27. pii: 201703650.
    PubMed     Text format    
    
    
    
26. MOU H, Moore J, Malonia SK, Li Y, et al
    Genetic disruption of oncogenic Kras sensitizes lung cancer cells to Fas receptor-mediated apoptosis.
    Proc Natl Acad Sci U S A. 2017 Mar 20. pii: 201620861.
    PubMed     Text format     Abstract available
    
    
    January 2017
27. TUNG B, Schade B, Cardiff RD, Aina OH, et al
    beta-Catenin haploinsufficiency promotes mammary tumorigenesis in an ErbB2-positive basal breast cancer model.
    Proc Natl Acad Sci U S A. 2017 Jan 17. pii: 201610383.
    PubMed     Text format     Abstract available
    
    
    
28. CHEN P, Zuo H, Xiong H, Kolar MJ, et al
    Gpr132 sensing of lactate mediates tumor-macrophage interplay to promote breast cancer metastasis.
    Proc Natl Acad Sci U S A. 2017 Jan 3. pii: 201614035.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Lung Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: